End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit

Annals of Neurology
A G EngelR C Griggs

Abstract

We describe a congenital myasthenic syndrome associated with severe end-plate (EP) acetylcholine receptor (AChR) deficiency not associated with an EP myopathy, and with evidence of immature AChR, containing the gamma instead of the epsilon subunit (gamma-AChR) at the EPs. Molecular genetic analysis of AChR-subunit genes revealed two mutations in the epsilon-subunit gene: insertion of a thymine after epsilon nucleotide 1101 (epsilon 11O1insT) that generates a nonsense codon directly, and insertion of a guanine after epsilon nucleotide 1293 (epsilon 1293insG) that generates three missense codons followed by a nonsense codon. Each mutation predicts truncation of the epsilon subunit at the level of the long cytoplasmic loop, between the third (M3) and fourth (M4) membrane spanning domains. The propositus' asymptomatic son carries epsilon 1293G, indicating that the two mutations are heteroallelic. Expression of AChR harboring either mutation in human embryonic kidney (HEK) fibroblasts was markedly reduced. Single-channel activity recorded from HEK cells expressing epsilon 11O1insT-AChR was infrequent but resembled activity of wild-type AChR channels in amplitude and open duration. No channel activity could be recorded from HEK cells...Continue Reading

References

Dec 1, 1990·The Journal of Cell Biology·P Blount, J P Merlie
Jun 12, 1989·Nucleic Acids Research·D BeesonJ Newsom-Davis
May 25, 1973·Science·J Patrick, J Lindstrom
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·K OhnoA G Engel
Aug 13, 1993·Cell·A B Sachs
Jun 21, 1993·Annals of the New York Academy of Sciences·A G Engel
Apr 21, 1995·Cell·C A Beelman, R Parker
Aug 18, 1994·Nature·D Muhlrad, R Parker
Jun 21, 1993·Annals of the New York Academy of Sciences·A G EngelJ Lindstrom
Jun 1, 1993·Brain : a Journal of Neurology·D O HutchinsonA G Engel
Jun 21, 1993·Annals of the New York Academy of Sciences·T J WallsV F Trastek
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S M Sine
Dec 1, 1995·Clinical and Experimental Pharmacology & Physiology·W D Phillips

❮ Previous
Next ❯

Citations

Mar 15, 2000·Muscle & Nerve·J M Lindstrom
Jan 1, 2003·Muscle & Nerve·Andrew G EngelSteven M Sine
Dec 13, 1997·Molecular Neurobiology·J Lindstrom
Mar 20, 2002·Current Neurology and Neuroscience Reports·Kinji Ohno, Andrew G Engel
Aug 19, 2009·Journal of Molecular Neuroscience : MN·Andrew G EngelSteven M Sine
Mar 31, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew G Engel
Jun 15, 1999·Brain Research. Molecular Brain Research·T NishizakiK Sumikawa
Oct 23, 1998·Journal of Physiology, Paris·C Léna, J P Changeux
Oct 23, 1998·Journal of Physiology, Paris·A G EngelS M Sine
Feb 7, 1998·Current Opinion in Neurobiology·C Léna, J P Changeux
Jun 26, 1999·Neuromuscular Disorders : NMD·F DeymeerC Ozdemir
Jul 17, 2003·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Sameer M Zuberi
Sep 27, 2003·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Kinji Ohno, Andrew G Engel
Mar 21, 2000·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·A G Engel
Oct 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michael WalogorskyPaul Brehm
Dec 15, 2010·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Mustafa A SalihThomas M Bosley
Jul 21, 1998·Annals of the New York Academy of Sciences·A G EngelS M Sine
Jul 21, 1998·Annals of the New York Academy of Sciences·L T MiddletonK Kyriallis
Jul 21, 1998·Annals of the New York Academy of Sciences·M MiloneA G Engel
Feb 28, 2007·Molecular and Cellular Biology·Debra A O'LearySika Ristevski
Jun 17, 2006·Annual Review of Neuroscience·Stephen C Cannon
Aug 3, 2005·The Journal of Clinical Investigation·Karin Jurkat-Rott, Frank Lehmann-Horn
Jun 8, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael WalogorskyPaul Brehm
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J Lindstrom
Mar 10, 1998·Molecular Membrane Biology·C Bouzat, F J Barrantes
Oct 15, 2013·Scientific Reports·Mohammad Alinoor RahmanKinji Ohno
Nov 1, 2003·Annals of the New York Academy of Sciences·David BeesonAngela Vincent
Nov 1, 2003·Annals of the New York Academy of Sciences·Andrew G EngelSteven M Sine
Aug 21, 2003·Muscle & Nerve·Ricardo A MaselliRobert L Wollmann
Jul 20, 2006·International Anesthesiology Clinics·Gilmore N O'Neill
Dec 28, 2007·Muscle & Nerve·Jennifer A AndersonRicardo A Maselli
Oct 18, 2005·Muscle & Nerve·Benjamin W HughesHenry J Kaminski
May 3, 2003·Nature Reviews. Neuroscience·Andrew G EngelSteven M Sine
Aug 10, 2007·Expert Reviews in Molecular Medicine·Juliane S MüllerHanns Lochmüller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.